Top Stories
The deal gives Takeda's discovery teams direct access to Boltz's newest biomolecular foundation models, including BoltzMol-1 and BoltzProt-1.
The AI image generator is developing a new form of medical imaging called "ultrasonic CT," which it says can scan the entire body in just 60 seconds.
The NFX-led financing round gives Portal runway through 2028 as it expands beyond drug screening into AI data generation and continues working on a DARPA-backed cell therapy manufacturing platform.
The Neuralink competitor is testing whether its fully implanted wireless BCI can preserve communication for people losing the ability to speak.
A fresh raise worth $17 million will help advance the biotech's preclinical programmes and expand its pharma collaborations.
Conference News
BERLIN--(BUSINESS WIRE)-- Pirche AG, a leader in digital molecular risk assessment, today announced a new collaboration to advance the field of transplant medicine and immunosuppression. In a strategi...
Company to Showcase Integration of AI, Digital Batch Records, and Intelligent Robotics to Accelerate Pharmaceutical ManufacturingAGOURA HILLS, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Oncotelic Thera...
CHICAGO – The American Society of Anesthesiologists (ASA) today announced Medtronic, a global leader in healthcare technology, has reaffirmed its commitment to ASA’s Corporate Supporter Program, conti...
Growing body of evidence supports AlloSure® as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomesData across kidney, heart, lung, and multi-organ transplantation...
Data, including seven oral presentations, highlight the clinical utility of Prospera™ across multiple organsAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DN...
